A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML

• Srila Gopal,
• Qing Lu,
• Joshua J. Man,
• Wendy Baur,
• Sitara P. Rao,
• Lev Litichevskiy,
• Malvina Papanastasiou,
• Amanda L. Creech,
• Katherine C. DeRuff,
• James Mullahoo,
• Adam Officer,
• Shawn B. Egri,
• Desiree Davison,
• Jacob D. Jaffe,
• Iris Z. Jaffe

Affiliations

Srila Gopal

Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA;

Qing Lu

Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA;

Joshua J. Man

Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA;

Wendy Baur

Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA;

Sitara P. Rao

Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA;

Lev Litichevskiy

Broad Institute of MIT and Harvard, Cambridge, MA

Malvina Papanastasiou

Broad Institute of MIT and Harvard, Cambridge, MA

Amanda L. Creech

Broad Institute of MIT and Harvard, Cambridge, MA

Katherine C. DeRuff

Broad Institute of MIT and Harvard, Cambridge, MA

James Mullahoo

Broad Institute of MIT and Harvard, Cambridge, MA

Adam Officer

Broad Institute of MIT and Harvard, Cambridge, MA

Shawn B. Egri

Broad Institute of MIT and Harvard, Cambridge, MA

Desiree Davison

Broad Institute of MIT and Harvard, Cambridge, MA

Jacob D. Jaffe

Broad Institute of MIT and Harvard, Cambridge, MA

Iris Z. Jaffe

Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA;; Iris Z. Jaffe, Molecular Cardiology Research Institute, Tufts Medical Center, 800 Washington St, Box 80, Boston, MA 02111;